aquestive.com (AQST) Company Sales Revenue

Symbol and logo of brand aquestive.com (AQST)

Aquestive Therapeutics (AQST) sales levels on the GURU.Markets chart demonstrate revenue dynamics, where 0.05 characterizes this valuation parameter. Growth is driven by modern oral films that are displacing injections. The strategy is based on the implementation of PharmFilm to replace traditional auto-injectors for allergy treatment. The reputation of Aquestive Therapeutics (AQST) is built on creating convenient therapy formats that improve patient medication adherence.

Aquestive Pharma (AQST): Company Revenue from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for aquestive.com (AQST)

- market price and analyst price targets:
Comprehensive company analysis:Aquestive Therapeutics
Core merchandise of Aquestive Therapeutics

For Aquestive Therapeutics (AQST), which is developing an express drug delivery system via soluble films, this indicator confirms the commercial demand for the new technology. The metric captures the actual daily cash inflow, separating real revenue from market noise. By analyzing the company's monthly sales, an investor can determine the stability of the cash flow and the business's stage of maturity. Growth in this figure indicates a patient shift toward the innovative standard of therapy, which confirms the fundamental resilience of the issuer's business model.

Competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|scpharmaceuticals.com (SCPH) - Company Sales|TECX: Revenue and Sales Volume|Tonix Pharmaceuticals - Company Sales Revenue|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP